Evaluation of the Pharmacokinetic Interaction between Lesogaberan (AZD3355) and Esomeprazole in Healthy Subjects

By Niazi Mohammad  

Drugs in R&D, Vol. 10, Iss. 4, 2010-11 ,pp. : 243-251

Adis International

Access to resources Recommend Favorite

Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects

By Bence Aimee K.   Anderson Eric B.   Halepota Maqbool A.   Doukas Michael A.   DeSimone Phillip A.   Davis George A.   Smith Deborah A.   Koch Kevin M.   Stead Andrew G.   Mangum Steve   Bowen Carolyn J.   Spector Neil L.   Hsieh Showchien   Adams Val R.  

Investigational New Drugs, Vol. 23, Iss. 1, 2005-01 ,pp. : 39-49

Springer Publishing Company

Access to resources Recommend Favorite

The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT 1B/1D receptor agonist

By Gupta P.   Butler P.   Shepperson N.B.   McHarg A.  

European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. : 73-81

Elsevier

Access to resources Recommend Favorite

Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers

By Dunbar G.   Boeijinga P.   Demazières A.   Cisterni C.   Kuchibhatla R.   Wesnes K.   Luthringer R.  

Psychopharmacology, Vol. 191, Iss. 4, 2007-05 ,pp. : 919-929

Springer Publishing Company

Access to resources Recommend Favorite

Involvement of GABA_B Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu₄ Receptor, LSP4-2022

By  

Current Neuropharmacology, Vol. 14, Iss. 5, 2016-06 ,pp. : 413-426

Bentham Science Publishers

Access to resources Recommend Favorite